DERIVADOS DE PRODROGA DE TRIAZOLPIRIDINAS SUSTITUIDAS

La presente invención se refiere a derivados de prodroga de inhibidores de la quinasa Mps-1 de fórmula (I), procesos para su preparación y su uso en el tratamiento y/o la profilaxis de enfermedades. The present invention relates to prodrug derivatives of Mps-1 kinase inhibitors, processes for their...

Full description

Saved in:
Bibliographic Details
Main Authors DONALD BIERER, DIRK KOSEMUND, VOLKER SCHULZE, ANTJE MARGRET WENGNER, DETLEF STÖCKIGT, PHILIP LIENAU, URSULA KRENZ, ULRICH LÜCKING, MICHAEL BRÜNING, GERHARD SIEMEISTER, IIDIKÓ TEREBESI, HANS-GEORG LERCHEN
Format Patent
LanguageSpanish
Published 06.01.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:La presente invención se refiere a derivados de prodroga de inhibidores de la quinasa Mps-1 de fórmula (I), procesos para su preparación y su uso en el tratamiento y/o la profilaxis de enfermedades. The present invention relates to prodrug derivatives of Mps-1 kinase inhibitors, processes for their preparation, and their use for the treatment and/or prophylaxis of diseases.
Bibliography:Application Number: NI20150000176